MORICI, NUCCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.414
AS - Asia 2.245
EU - Europa 2.223
SA - Sud America 289
AF - Africa 66
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.277
Nazione #
US - Stati Uniti d'America 2.330
GB - Regno Unito 835
CN - Cina 676
SG - Singapore 530
IT - Italia 359
HK - Hong Kong 308
BR - Brasile 211
RU - Federazione Russa 183
VN - Vietnam 162
SE - Svezia 158
DE - Germania 130
IN - India 105
FR - Francia 97
BD - Bangladesh 77
FI - Finlandia 77
IE - Irlanda 75
DK - Danimarca 69
NL - Olanda 65
ID - Indonesia 63
KR - Corea 52
JP - Giappone 51
CA - Canada 45
TR - Turchia 38
AU - Australia 37
ES - Italia 31
TW - Taiwan 25
MX - Messico 24
EG - Egitto 22
AR - Argentina 21
IR - Iran 20
GR - Grecia 19
IQ - Iraq 19
AT - Austria 18
UA - Ucraina 18
BE - Belgio 17
PH - Filippine 17
PL - Polonia 17
CL - Cile 16
CO - Colombia 16
PK - Pakistan 15
ZA - Sudafrica 13
TH - Thailandia 12
SA - Arabia Saudita 11
EC - Ecuador 10
JO - Giordania 10
RO - Romania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
IL - Israele 8
NO - Norvegia 8
CI - Costa d'Avorio 7
MU - Mauritius 5
PE - Perù 5
SI - Slovenia 5
CR - Costa Rica 4
PT - Portogallo 4
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
KE - Kenya 3
KG - Kirghizistan 3
LY - Libia 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
MY - Malesia 3
OM - Oman 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BW - Botswana 1
BZ - Belize 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
Totale 7.277
Città #
Southend 755
Singapore 270
Hong Kong 262
Ashburn 251
Fairfield 162
San Jose 119
Beijing 105
Milan 99
Chandler 96
Los Angeles 91
Wilmington 89
Houston 87
Redwood City 78
Dallas 76
Princeton 74
Council Bluffs 73
Ann Arbor 72
Dublin 70
Woodbridge 69
Helsinki 64
Dearborn 58
Cambridge 55
Seattle 54
Phoenix 53
Santa Clara 46
New York 42
Ho Chi Minh City 41
Frankfurt am Main 39
Jakarta 39
Lauterbourg 38
Buffalo 34
Moscow 33
Nanjing 33
Guangzhou 30
Shanghai 30
Hanoi 29
Des Moines 27
Rome 27
Bengaluru 26
São Paulo 26
Istanbul 24
Seoul 21
Tianjin 21
Jinan 18
Dong Ket 17
Tokyo 17
Munich 16
Cangzhou 15
Boardman 14
Changsha 14
Shenyang 14
Taipei 14
Atlanta 13
Cairo 13
Columbus 13
Washington 13
Brussels 12
Chicago 12
Hebei 12
Hefei 12
Oegstgeest 12
Santiago 12
Baghdad 11
Hanover 11
Kunming 11
London 11
Nuremberg 11
San Diego 11
Amman 10
Central District 10
Hangzhou 10
Nottingham 10
Toronto 10
Wuhan 10
Brisbane 9
Catania 9
Da Nang 9
Suri 9
Montreal 8
Silver Spring 8
Tashkent 8
Abidjan 7
Athens 7
Curitiba 7
Fuzhou 7
Haiphong 7
Johannesburg 7
Lappeenranta 7
Multan 7
New Delhi 7
Polska 7
Rijswijk 7
Vienna 7
Zhengzhou 7
Boston 6
Cagliari 6
Chennai 6
Nashville 6
Orem 6
Ottawa 6
Totale 4.364
Nome #
Anemia and acute coronary syndrome: current perspectives 721
Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes 560
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection : Time to Rethink 368
TREATMENT OF ACUTE CORONARY SYNDROMES IN OLDER ADULTS 344
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 331
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome 314
Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention 313
Antithrombotic therapy in ventricular assist device (VAD) management : from ancient beliefs to updated evidence : a narrative review 231
Protracted aortic valve closure during peripheral veno-arterial extracorporeal life support: is intra-aortic balloon pump an effective solution? 219
Long-term survival and major outcomes in post-cardiotomy extracorporeal membrane oxygenation for adult patients in cardiogenic shock 212
Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel 208
Vasopressors and inotropes in cardiogenic shock : Is there room for "adrenaline resuscitation" ? 194
Use of PRECISE-DAPT Score and Admission Platelet Count to Predict Mortality Risk in Patients with Acute Coronary Syndrome 182
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients : The X-COVID-19 randomized trial 179
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 166
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 164
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy : Insights from Two Contemporary Nationwide Registries 161
Alterazioni dell’emocromo nella sindrome coronarica acuta: ematologi e cardiologi a confronto [Relevance of complete blood count parameters in the assessment of acute coronary syndromes: a combined hematological and cardiological perspective] 160
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial 155
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 154
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 147
Recurrent stent thrombosis in a patient with acute coronary syndrome and ischemic colitis: between life-threatening thrombosis and life-threatening bleeding 147
Cangrelor bridging strategy for liver damage after mechanical chest compression 142
Fifteen years trends of cardiogenic shock and mortality in patients with diabetes and acute coronary syndromes 131
Cardiogenic Shock Integrated PHenotyping for Event Reduction: A Pilot Metabolomics Analysis 124
Non-ST-elevation acute coronary syndrome in chronic kidney disease: prognostic implication of an early invasive strategy 122
Real-world application of currently available decision models for dual antiplatelet therapy duration in acute coronary syndrome 116
Characteristics and Outcome of Patients ≥75 Years of Age With Prior Coronary Artery Bypass Grafting Admitted for an Acute Coronary Syndrome 116
Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial 112
A Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 107
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction 107
De-escalating dual antiplatelet therapy in patients with acute coronary syndromes : the right strategy to harmonize time-dependent ischemic and bleeding risk in elderly patients? 107
Impact of body mass index on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: Insights from the ELDERLY ACS 2 trial 106
Long-term risk of major adverse cardiovascular events in patients with acute coronary syndrome: prognostic role of complete blood cell count 104
Getting to the heart of the matter in a multisystem disorder: Erdheim–Chester disease 102
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 92
Psoriasis and the risk of acute coronary syndrome in the elderly 90
The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials 83
Assessing bleeding in acute coronary syndrome using the Bleeding Academic Research Consortium definition 82
Use of Clinical Risk Score in an Elderly Population : Need for Ad Hoc Validation and Calibration 75
Totale 7.548
Categoria #
all - tutte 19.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 0 51 86
2021/2022624 81 55 49 58 32 38 34 68 48 51 20 90
2022/2023627 63 57 65 33 61 110 29 20 91 18 40 40
2023/2024464 18 52 27 36 68 31 41 27 14 38 47 65
2024/20251.053 41 124 28 94 71 68 58 121 73 82 96 197
2025/20262.386 248 184 244 194 191 142 491 95 235 146 216 0
Totale 7.548